Support and Membership

The CiRA Foundation was founded in 2020 to operate the iPS Cell Stock Project and advance related regenerative medicine. It succeeds the Center for iPS Cell Research and Application (CiRA), Kyoto University in this role.

CiRA is still seeking support for the iPS Cell Research Fund. Please see here for donations to the fund.

Significance of your support

CiRA Foundation is soliciting donations for the operations as a public interest incorporated foundation.

  • The major issue for practical application is the "translational function to industry." The functions will be realized in a stable organizational structure.
  • The innovative medicines are expensive, however it will be possible to continue manufacturing and providing iPS cells at a reasonable price.
  • The new medical treatment will be deliver as soon as possible to patients suffering from diseases and injuries that can not be cured now.